Business, energy, technology, markets and global industry news from Business News Today

XACDURO

PharmaDeviceNews XACDURO
Innoviva’s XACDURO, ZEVTERA and NUZOLVENCE highlight the company’s expanding antimicrobial portfolio after all three therapies were named finalists for the 2026 Prix Galien USA Best Pharmaceutical Product Award. Representative image.
Pharma & Biotech

Three antibiotics, three different AMR battles: why Innoviva’s Prix Galien triple could matter beyond the awards

Innoviva’s XACDURO, ZEVTERA and NUZOLVENCE reach the 2026 Prix Galien finals, spotlighting a growing anti-infective portfolio.

Read More
Zai Lab prepares to report second-quarter 2026 results as investors assess revenue recovery, new China product launches and progress across its oncology and neuroscience pipeline. Representative image.
Pharma & Biotech

Zai Lab’s August 6 earnings could reveal whether its 2026 commercial reset is starting to work

Zai Lab reports Q2 2026 results on August 6 as investors assess revenue pressure, COBENFY and TIVDAK launches, and zoci pipeline progress.

Read More